Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00690690 · ClinicalTrials.gov registry record · Phase 2
No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 370
- Enrollment target
NCT00690690: Completed Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT00690690 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 370 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (178% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00690690, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 370 participants
- Enrollment target
Study Summary
The overall goal of this study is to develop and evaluate a brief, video-based, group-level intervention designed to reduce sexual risk taking among culturally diverse English- and Spanish-speaking Latino men who have sex with men (MSM).
Interventions
- BEHAVIORAL HCT
- BEHAVIORAL Video (group-delivered video-based intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
What the finished NCT00690690 record still lists
NCT00690690 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (178% higher).
The record links to 0 conditions, and to 2 interventions - of which HCT is the first listed.
NCT00690690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00690690 about?
NCT00690690 is a clinical study titled "No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks". The overall goal of this study is to develop and evaluate a brief, video-based, group-level intervention designed to reduce sexual risk taking among culturally diverse English- and Spanish-speaking Latino men who have sex with men (MSM).
What is the current status of trial NCT00690690?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 370 participants. The study started on 2008-06. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00690690?
The interventions under investigation include: HCT (BEHAVIORAL), Video (group-delivered video-based intervention) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00690690?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00690690's enrollment target sits among peer trials
370 120th of 2000 higher than 1,880 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia